Phase I trial of GlaxoSmithKline’s Ebola vaccine shows it is well tolerated No major adverse events were reported in an Ebola vaccine phase I trial involving 20 volunteers.…
New roles explored for nucleoside reverse transcriptase inhibitors New research suggests nucleoside reverse transcriptase inhibitors (NRTIs) have intrinsic anti-inflammatory activity through suppression of NLRP3 inflammasome.…
Rise in endocarditis cases reported after change in antibiotic policy A reduction in antibiotic prophylaxis for dental procedures after a change in UK policy was paralleled by an increase in cases of infective endocarditis.…
Metformin shows promise as anti-tuberculosis drug A promising candidate in the search for alternative treatments for Mycobacterium tuberculosis is the antidiabetic drug metformin.…
Inquiry criticises NHS Greater Glasgow and Clyde for failure to appoint antimicrobial pharmacist Failure to adopt ’prudent’ antibiotic prescribing practices contributed to the deaths of 34 hospital patients from Clostridium difficile infection.…
Community pharmacists could screen at-risk groups for liver disease According to The Lancet’s commission, community pharmacists could play a key role in helping to improve liver disease services in primary care, say hepatology specialists.…
Assessing suspected food poisoning cases in the UK With more than 20,000 patients hospitalised in the UK each year because of food poisoning, quick assessment is essential.…
Mind-altering parasitesSteve Bremer describes different types of parasitic infection that can cause behavioural changes in humans.…
Hospital workers wash their hands less frequently as their shifts progress Hospital employees who work with patients wash their hands less frequently as they get deeper into their shifts, a study finds.…
UNAIDS sets target of 90% of people with HIV receiving treatment by 2020A fast-track approach is needed over the next five years for the AIDS epidemic to cease to be a global health threat by 2030, according to a report by UNAIDS released on 18 November 2014.…